Molecules (Apr 2019)

Advances in the Understanding of Skin Cancer: Ultraviolet Radiation, Mutations, and Antisense Oligonucleotides as Anticancer Drugs

  • Kateryna V. Laikova,
  • Volodymyr V. Oberemok,
  • Alisa M. Krasnodubets,
  • Nikita V. Gal’chinsky,
  • Refat Z. Useinov,
  • Ilya A. Novikov,
  • Zenure Z. Temirova,
  • Mikhail V. Gorlov,
  • Nikita A. Shved,
  • Vadim V. Kumeiko,
  • Tatiana P. Makalish,
  • Evgeniya Y. Bessalova,
  • Iryna I. Fomochkina,
  • Andrey S. Esin,
  • Mikhail E. Volkov,
  • Anatoly V. Kubyshkin

DOI
https://doi.org/10.3390/molecules24081516
Journal volume & issue
Vol. 24, no. 8
p. 1516

Abstract

Read online

Skin cancer has always been and remains the leader among all tumors in terms of occurrence. One of the main factors responsible for skin cancer, natural and artificial UV radiation, causes the mutations that transform healthy cells into cancer cells. These mutations inactivate apoptosis, an event required to avoid the malignant transformation of healthy cells. Among these deadliest of cancers, melanoma and its ‘younger sister’, Merkel cell carcinoma, are the most lethal. The heavy toll of skin cancers stems from their rapid progression and the fact that they metastasize easily. Added to this is the difficulty in determining reliable margins when excising tumors and the lack of effective chemotherapy. Possibly the biggest problem posed by skin cancer is reliably detecting the extent to which cancer cells have spread throughout the body. The initial tumor is visible and can be removed, whereas metastases are invisible to the naked eye and much harder to eliminate. In our opinion, antisense oligonucleotides, which can be used in the form of targeted ointments, provide real hope as a treatment that will eliminate cancer cells near the tumor focus both before and after surgery.

Keywords